204 related articles for article (PubMed ID: 22451327)
1. The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco.
Hermanstyne KA; Bangsberg DR; Hennessey K; Weinbaum C; Hahn JA
J Public Health (Oxf); 2012 Aug; 34(3):330-9. PubMed ID: 22451327
[TBL] [Abstract][Full Text] [Related]
2. HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.
Page K; Yu M; Cohen J; Evans J; Shumway M; Riley ED
BMC Public Health; 2017 Feb; 17(1):171. PubMed ID: 28173785
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
Facente SN; Grinstein R; Bruhn R; Kaidarova Z; Wilson E; Hecht J; Burk K; Grebe E; Morris MD
PLoS One; 2022; 17(5):e0267902. PubMed ID: 35544483
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection in San Francisco's HIV-infected urban poor.
Hall CS; Charlebois ED; Hahn JA; Moss AR; Bangsberg DR
J Gen Intern Med; 2004 Apr; 19(4):357-65. PubMed ID: 15061745
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
[TBL] [Abstract][Full Text] [Related]
8. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hepatitis C virus infection among street youths.
Roy E; Haley N; Leclerc P; Boivin JF; Cédras L; Vincelette J
CMAJ; 2001 Sep; 165(5):557-60. PubMed ID: 11563207
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatitis C virus infection among homeless adults.
Nyamathi AM; Dixon EL; Robbins W; Smith C; Wiley D; Leake B; Longshore D; Gelberg L
J Gen Intern Med; 2002 Feb; 17(2):134-43. PubMed ID: 11841529
[TBL] [Abstract][Full Text] [Related]
11. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C and substance use in a sample of homeless people in New York City.
Rosenblum A; Nuttbrock L; McQuistion HL; Magura S; Joseph H
J Addict Dis; 2001; 20(4):15-25. PubMed ID: 11760923
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.
Gelberg L; Robertson MJ; Arangua L; Leake BD; Sumner G; Moe A; Andersen RM; Morgenstern H; Nyamathi A
Public Health Rep; 2012; 127(4):407-21. PubMed ID: 22753984
[TBL] [Abstract][Full Text] [Related]
14. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
[TBL] [Abstract][Full Text] [Related]
15. Revolving doors: imprisonment among the homeless and marginally housed population.
Kushel MB; Hahn JA; Evans JL; Bangsberg DR; Moss AR
Am J Public Health; 2005 Oct; 95(10):1747-52. PubMed ID: 16186453
[TBL] [Abstract][Full Text] [Related]
16. Sharing of noninjection drug-use implements as a risk factor for hepatitis C.
Tortu S; McMahon JM; Pouget ER; Hamid R
Subst Use Misuse; 2004 Jan; 39(2):211-24. PubMed ID: 15061559
[TBL] [Abstract][Full Text] [Related]
17. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination?
Hennessey KA; Bangsberg DR; Weinbaum C; Hahn JA
Public Health Rep; 2009; 124(6):813-7. PubMed ID: 19894423
[TBL] [Abstract][Full Text] [Related]
19. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
[TBL] [Abstract][Full Text] [Related]
20. Exposure to hepatitis C virus in homeless men in Central Brazil: a cross-sectional study.
Ferreira PM; Guimarães RA; Souza CM; Guimarães LC; Barros CV; Caetano KA; Rezza G; Spadoni L; Brunini SM
BMC Public Health; 2017 Jan; 17(1):90. PubMed ID: 28100196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]